Simvastatin increases the in vivo activity of the first-line tuberculosis regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen

Published:2014-05-22 Issue:9 Volume:69 Page:2453-2457
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Skerry C.,Pinn M. L.,Bruiners N.,Pine R.,Gennaro M. L.,Karakousis P. C.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Reference19 articles.

1. New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

2. The Global Alliance for Tuberculosis Drug Development—Accomplishments and Future Directions

3. The Need for New Drugs against Tuberculosis

4. Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas

5. Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update to Novel Therapeutic Options for Combating Tuberculosis: Challenges and Future Prospectives;Current Pharmaceutical Biotechnology;2024-10

2. Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens;Antibiotics;2024-09-02

3. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning;Frontiers in Pharmacology;2024-06-07

4. Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics;Cell Host & Microbe;2024-06

5. The antimicrobial activity of innate host-directed therapies: A systematic review;International Journal of Antimicrobial Agents;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3